Visionary Holdings Regains Nasdaq Compliance
Visionary Holdings has regained compliance with Nasdaq Listing Rule 5250(c)(1) in connection with the filing of its Annual Report on Form 20-F for the fiscal year ended March 31, 2025. As previously disclosed, on August 5, 2025, the Company was notified by Nasdaq that it was not in compliance with the periodic filing requirement under Nasdaq Listing Rule 5250(c)(1) due to the delayed filing of its Annual Report on Form 20-F for the fiscal year ended March 31, 2025. Based on the Company's filing of its Form 20-F on January 28, 2026, Nasdaq has determined that the Company has now regained compliance with the applicable listing requirements. On January 29, 2026, Nasdaq advised the Company that this matter is now closed.
Trade with 70% Backtested Accuracy
Analyst Views on GV
About GV
About the author

- Compliance Notification: Visionary Holdings received a notification from Nasdaq indicating non-compliance with the minimum bid price requirement, as its common shares closed below $1.00 for 30 consecutive business days, highlighting the compliance pressures faced by the company.
- Price Fluctuation: As of the latest trading session, GV's stock price increased by 2.07% to $0.31, although it remains below Nasdaq's minimum requirement, reflecting market caution regarding the company's future performance.
- Continued Listing Impact: Despite the notification, GV's common shares will continue to trade on the Nasdaq Capital Market, indicating that the company will not face immediate delisting risks, but it must take measures to restore compliance status.
- Market Reaction: This compliance notification may affect investor confidence, and GV needs to improve its financial performance and stock price to rebuild market trust, ensuring its long-term survival on Nasdaq.
- Nasdaq Warning Notification: Visionary Holdings received a notification from Nasdaq on April 7, 2026, indicating non-compliance with the minimum bid price requirement as its common shares traded below $1.00 for 30 consecutive business days from February 23 to April 6, potentially jeopardizing its listing on the Nasdaq Capital Market.
- Compliance Period Established: Under Nasdaq Rule 5810(c)(3)(A), the company has been granted an initial compliance period of 180 days until October 5, 2026, to regain compliance, with the possibility of restoring compliance if the share price reaches $1.00 for at least ten consecutive business days during this timeframe.
- Potential Consequences Analysis: Should the company fail to regain compliance within the stipulated period, it may be eligible for an additional 180-day compliance period, contingent upon meeting other listing standards, and may need to consider a reverse stock split to address the bid price deficiency, increasing future uncertainties for the company.
- Company Response Strategy: Visionary Holdings intends to actively monitor the closing bid price of its common shares and will evaluate all available options to regain compliance with Nasdaq's minimum bid price requirement within the designated compliance period, thereby ensuring its continued presence in the capital market.
Stock Price Decline: Shares of Visionary Holdings Inc. (GV) fell by 5% after the company received a notice from Nasdaq for failing to comply with listing requirements.
Compliance Issue: The issue arose from GV's failure to file the required Form 6-K with interim financial statements for its second fiscal quarter.
Deadline for Compliance: GV has 60 days, until June 1, to submit a compliance plan, which, if accepted, could extend the deadline for compliance up to 180 days.
Trading Status: GV shares have been trading below $1 since February 24, 2026, indicating ongoing financial challenges for the company.
- Compliance Notification: Visionary Holdings received a deficiency letter from Nasdaq on April 2, 2026, indicating non-compliance due to the failure to timely file Form 6-K containing interim financial statements for the second fiscal quarter, which jeopardizes its listing status.
- Rectification Period: The company has been granted a 60-day period to submit a compliance plan by June 1, 2026; if accepted, this could extend the deadline to September 28, 2026, but failure to comply may lead to delisting proceedings.
- Market Impact: While the deficiency letter does not immediately affect the trading of the company's shares, maintaining compliance with other listing requirements is crucial to avoid potential delisting, which could adversely affect shareholder interests.
- Management Commitment: The management is committed to fulfilling financial reporting obligations promptly to uphold Nasdaq listing standards, demonstrating a strong focus on compliance and shareholder protection.

- Strategic Investment Agreement: Visionary Holdings has signed an Investment Cooperation Agreement with Qingdao Xihai Rongke Enterprise Management Co., Ltd., planning a $20 million investment for its anti-aging project in Qingdao, aimed at establishing a project company to enhance the company's influence in the Chinese market.
- Project Company Establishment: Under the agreement, the parties will jointly establish a project company focused on research and translational development in cell therapy and biologics, expected to drive the introduction of internationally aligned products and services, thereby expanding business in the Shandong market.
- Phased Investment Structure: The investment will be structured in two phases, with the initial $20 million disbursed through three milestone payments, ensuring the project company operates smoothly and achieves profitability, targeting profitability for the first anti-aging center within one year post-investment completion.
- Regional Support Measures: The agreement includes a range of implementation support measures, such as coordinating local resources in Qingdao, providing preferential office and R&D space, aimed at accelerating project implementation and enhancing the company's competitiveness in the life sciences sector.
- Strategic Cooperation Agreement: Visionary Holdings Inc. has signed a strategic cooperation agreement with Zhejiang Chushanji Digital Technology Co., Ltd. to leverage Chushanji's extensive offline commercial network in China, which spans nearly 10,000 stores, significantly enhancing the market penetration of its V-series anti-aging products.
- Market Potential Assessment: Based on preliminary internal estimates, if the collaboration progresses as expected, the annual revenue contribution from related products could potentially reach between $10 million and $15 million, providing crucial support for the company's commercialization strategy in the Chinese market.
- Channel Development Advantage: Chushanji's extensive network across five provinces and 105 district and county markets will offer Visionary a broad base of service locations and consumer touchpoints, thereby enhancing its market access capabilities in the medical aesthetics and wellness sectors, driving product sales and brand awareness.
- Execution Risk Advisory: While the initial phase of the cooperation shows promising market potential, the company emphasizes that actual results will be influenced by market demand, execution efficiency, and regulatory factors, making future financial impacts uncertain and warranting cautious consideration.







